Human genome and diseases: Review double-strand breaks and translocations in cancer

Cellular and Molecular Life Sciences

Volumn 59, Issue 2, 2002, Pages 373-385

  Elliott, B ^a   Jasin, M ^a  

^a Weill Cornell Medical Center   (United States)

Author keywords

Cancer; DNA repair pathways; Double strand breaks; Recombination; Translocations

Indexed keywords

DNA;

CARCINOGENESIS; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; DNA REPAIR; DNA STRAND BREAKAGE; GENE EXPRESSION; HUMAN; HUMAN GENOME; MAMMAL CELL; PROTO ONCOGENE; REVIEW; SARCOMA; BIOLOGICAL MODEL; BLOOD DISEASE; BURKITT LYMPHOMA; CHRONIC MYELOID LEUKEMIA; DNA DAMAGE; GENE REARRANGEMENT; GENE TRANSLOCATION; GENETICS; NEOPLASM; SMALL CELL CARCINOMA;

MAMMALIA;

BURKITT LYMPHOMA; CARCINOMA, SMALL CELL; DNA DAMAGE; DNA REPAIR; GENE REARRANGEMENT; HEMATOLOGIC NEOPLASMS; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MODELS, GENETIC; NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 0036480427     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-002-8429-3     Document Type: Review

References (112)

1. Genes altered by chromosomal translocations in leukemias and lymphomas
2. Chromosome rearrangements in human solid tumor
3. Recurrent chromosome aberrations in cancer
4. Chromosomal translocation in human cancer
5. The critical role of chromosome translocations in human leukemias
6. A minute chromosome in human granulocytic leukemia
7. Differential binding of alkylating fluorochromes in human chromosomes
8. Identificaton of a translocation with quinacrine fluorescence in a patient with acute leukemia
9. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining
10. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells
11. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells
12. Detection of chromosome aberrations in metaphase and interphase tumor cells by in situ hybridization using chromosome-specific library probes
13. Molecular cytogenetics in human cancer diagnosis
14. Multicolor spectral karyotyping of human chromosomes
15. Karyotyping human chromosomes by combinatorial multi-fluor FISH
16. DNA topoisomerase poisons as antitumor drugs
17. The RAG proteins and V(D)J recombination: Complexes, ends and transposition
18. Meiosis-specific DNA double-strand breaks are catalyzed by Spo 11, a member of a widely conserved protein family
19. Double-strand break repair and homologous recombination in mammalian cells
20. Introduction of doublestrand breaks into the genome of mouse cells by expression of a rare-cutting endonuclease
21. Homology-directed repair is a major double-strand break repair pathway in mammalian cells
22. Homologous and non-homologous recombination differentially affect DNA damage repair in mice
23. Homologous recombination and non-homologous end-joining pathways of DNA double-strand repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells
24. Coupled homologous and nonhomologous repair of a double-strand break preserves genomic integrity in mammalian cells
25. Perspective: Chromosomal translocations can affect genes controlling gene expression and differentiation - Why are these functions targeted?
26. Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphoma
27. Differential expression of the translocated and the untranslocated c- myc oncogene in Burkitt lymphoma
28. Activation of a translocated human c-myc gene by an enhancer in the immunoglobulin heavy-chain locus
29. Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma
30. Oncogenic activity of the c-Myc protein requires dimerization with Max
31. Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity
32. Max: Functional domains and interaction with c-Myc
33. Transcriptional activation of an unrearranged and untranslocated c-myc oncogene by translocation of a C lambda locus in Burkitt
34. Translocation of an immunoglobulin kappa locus to a region 3 of an unrearranged c-myc oncogene enhances c-myc transcription
35. Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma
36. Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia
37. HOX11, a homeobox-conraining T-cell oncogene on human chromosome 10q24
38. Translocation of c-ab 1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia
39. Fused transcript of abl and bcr genes in chronic myelogeneous leukemia
40. Characterization of the BCR promoter in Philadelphia chromosome-positive and -negative cell lines
41. 1 translocation
42. The first intron in the human c-abl gene is at least 200 kilobases long and is a target for translocations in chronic myelogenous leukemia
43. The BCR gene and Philadelphia chromosome-positive leukemogenesis
44. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity
45. Tyrosine kinase activity and transformation potency of bcr-abl oncogene products
46. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome
47. Clinical and biologic hallmarks of the Philadelphia chromosome in childhood acute lymphoblastic leukemia
48. Biological implications of consistent chromosome rearrangements in leukemia and lymphoma
49. A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia
50. Intra-abdominal desmoplastic small round-cell tumor. Report of 19 cases of a distinctive type of high-grade polyphenotypic malignancy affecting young individuals
51. A novel reciprocal chromosome translocation t(11;22) (p13;q12) in an intraabdominal desmoplastic small round-cell tumor
52. Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor
53. The desmoplastic small round cell tumor t(11;22) translocation produces EWS/WT1 isoforms with differing oncogenic properties
54. Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor
55. The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains
56. The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI1
57. hTAF(II)68, a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II
58. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma
59. A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP
60. Wilms tumor and the WT1 gene
61. WTl-mediated growth suppression of Wilms tumor cells expressing a WT 1 splicing variant
62. Novel oncogenic mutations in the WT1 Wilms' tumor suppressor gene: A t(11;22) fuses the Ewing's sarcoma gene, EWS1 to WT1 in desmoplastic small round cell tumor
63. The IGF-1 receptor gene promoter is a molecular target for the Ewing's sarcoma-Wilms' tumor 1 fusion protein
64. The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour
65. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
66. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts
67. DNA breakage and repair
68. Mechanism of V(D)J recombination
69. Chromosomal stability and the DNA double-stranded break connection
70. The nature of human gene mutation
71. Rearrangement of the human tre oncogene by homologous recombination between Alu repeats of nucleotide sequences from two different chromosomes
72. AT-rich palindromes mediate the constitutional t(11;22) translocation
73. Palindrome resolution and recombination in the mammalian germ line
74. Illegitimate recombination mediated by calf thymus DNA topoisomerase II in vitro
75. Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors
76. A precise interchromosomal reciprocal exchange between hot spots for cleavable complex formation by topoisomerase II in amsacrine-treated Chinese hamster ovary cells
77. Secondary leukemias induced by topoisomerase-targeted drugs
78. A close association between sites of DNase I hypersensitivity and sites of enhanced cleavage by micrococcal nuclease in the 5′-flanking region of the actively transcribed ovalbumin gene
79. Dysfunction of chromosomal loop attachment sites: Illegitimate recombination linked to matrix association regions and topoisomerase II
80. DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis
81. Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes
82. Chromosomal translocations in lymphoid neoplasia: A reappraisal of the recombinase model
83. Recent advances in understanding V(D)J recombination
84. The mechanism of V(D)J joining: Lessons from molecular, immunological and comparative analyses
85. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining
86. Analysis of the V(D)J recombination efficiency at lymphoid chromosomal translocation breakpoints
87. Cryptic signals and the fidelity of V(D)J joining
88. Mechanism of the t(14;18) chromosomal translocation: Structural analysis of both derivative 14 and 18 reciprocal partners
89. DNA transposition by the RAG1 and RAG2 proteins: A possible source of oncogenic translocations
90. Clonal selection and learning in the anti-body system
91. Ku80 is required for immunoglobulin isotype switching
92. Towards an understanding of somatic hypermutation
93. Cellular origin of human B-cell lymphomas
94. Chromosome translocation based on illegitimate recombination in human tumors
95. Molecular biology of the Ewing's sarcoma/primitive neuroectodermal tumor family
96. A DNA damage repair mechanism is involved in the origin of chromosomal translocations t(4;11) in primary leukemic cells
97. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia
98. Frequent chromosomal translocations induced by DNA double-strand breaks
99. Double-strand break repair by interchromosomal recombination: Suppression of chromosomal translocations
100. Lack of chromosome territoriality in yeast: Promiscuous rejoining of broken chromosome ends
101. Repair of double-strand breaks by homologous recombination in mismatch repair-defective mammalian ceils
102. Gene conversion tracts from double-strand break repair in mammalian cells
103. Alu: Structure, origin, evolution, significance and function of one-tenth of human DNA
104. Brcal controls homology-directed DNA repair
105. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells
106. Multiple pathways of recombination induced by double-strand breaks in Saccharomyces cerevisiae
107. DNA double-strand breaks: Signaling, repair and the cancer connection
108. Inducible chromosomal translocation of AML1 and ETO genes through Cre/loxP-mediated recombination in the mouse
109. Inter-chromosomal recombination of M11 and Af9 genes mediated by cre-loxP in mouse development
110. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia